OvaScience is focused on the discovery, development and commercialization of new treatments for female infertility. Utilizing patented technology, OvaScience is translating innovative research in egg precursor germline stem cells to make in vitro fertilization (IVF) safer and more effective. 

OvaScience merged with Millendo Therapeutics
(Nasdaq:MLDN)